Heterogeneous nuclear ribonucleoprotein A1 pseudogene 16 (HNRNPA1P16)

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 16 (HNRNPA1P16) is classified as a pseudogene within the human genome, specifically related to the parental HNRNPA1 gene but not encoding a functional protein product. Pseudogenes like HNRNPA1P16 may originate from gene duplication or retrotransposition events; although some pseudogenes are transcribed and may regulate gene expression through RNA-mediated mechanisms (such as acting as competing endogenous RNAs, or ceRNAs), there is currently no evidence in the literature or major databases that HNRNPA1P16 has any functional products, roles as a receptor, enzyme, or drug target, or direct implications in human disease. Most research and drug development efforts are focused on the canonical HNRNPA1 gene (a protein-coding RNA-binding protein involved in splicing, mRNA transport, and oncogenesis), not on pseudogenes like HNRNPA1P16. Thus, HNRNPA1P16 is not considered a therapeutic target, receptor, enzyme, transporter, or member of other classical drug target families, and its inclusion as a named target is likely incorrect or non-informative in drug discovery or translational research contexts.